This Day in the Yesteryear: VIOXX WITHDRAWN FROM MARKET BECAUSE OF CARDIOVASCULAR CONCERNS (2004)

Vioxx Withdrawn from Market Because of Cardiovascular Concerns (2004)

Merck’s COX-2 selective nonsteroidal anti-inflammatory drug Vioxx (rofecoxib) was approved for use in the US in 1999 and remained on the market for just five years before being pulled due to concerns that it could raise the risk of heart attack and stroke. By that time, some 80 million people worldwide had taken the drug, primarily to treat osteoarthritis, acute pain, and dysmenorrhea. Before long, the drugmaker found itself facing thousands of lawsuits. How much did it earmark for settlements? More… Discuss

 

Advertisements

Leave a Reply: (What... You're shy?)

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s